Bookmark

Add to MyYahoo RSS

Ranbaxy Laboratories News

News on Ranbaxy Laboratories (Ticker: RBXLY) continually updated from thousands of sources around the net.

Wednesday | Business Journal

Generic drug settlement brings healthy round of funds to Oregon

The Oregon Department of Justice and Ranbaxy Laboratories, along with two affiliated U.S. companies, have reached a $2.3 million court settlement regarding the drugs.

Comment?

Related Topix: Oregon Government, Oregon, Ranbaxy Laboratories, Biotech, Healthcare Industry

Tue Jul 08, 2014

The Oregonian

Generic drugmaker Ranbaxy Laboratories will pay Oregon $2.3 million over bad drugs

An India-based generic drug giant, Ranbaxy Laboratories, will pay Oregon $2.3 million after last year admitting to crimes including selling substandard or untested medicines.

Comment?

Related Topix: Oregon, Oregon Government, Biotech, Ranbaxy Laboratories, Healthcare Industry, Marketing

Fri Jun 27, 2014

Freshnews

Ohm Laboratories to Launch Valsartan Tablets

Ohm Laboratories, Inc. , a wholly owned subsidiary of Ranbaxy Laboratories Limited , announced today that Ohm has received approval from the U.S. Food and Drug Administration to manufacture and market Valsartan 40 mg, 80 mg, 160 mg, and 320 mg tablets on an exclusive basis.

Comment?

Related Topix: Medicine, Diovan, Valsartan (generic), Biotech, Ranbaxy Laboratories, Healthcare Industry, Food and Drug Administration, Hypertension, Health, Marketing

Thu Jun 26, 2014

The Jersey Journal

NJ Ranbaxy lab approved to make generic blood pressure drug from Novartis

Ranbaxy Laboratories won U.S. approval to make a generic version of Diovan, a blood pressure drug from Novartis, almost two years after the $3.5 billion medicine lost patent protection from low-cost competition.

Comment?

Related Topix: Biotech, Ranbaxy Laboratories, Healthcare Industry, World News, India,

•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••